Working for continuing education & training for clinicians, scientists and community

Luc Bidaut

BidautL_pict-1

Luc Bidaut, PhD

Luc Bidaut moved to Dundee in July 2010 as Chair of Translational Imaging and Director of Imaging for the Centre of Oncology and Molecular Medicine (COMM). Soon thereafter, he created the Imaging & Technology Core Group (ITCG), a new multidisciplinary institutional construct to regroup most relevant entities and stakeholders under a common virtual umbrella. Following the restructuring of the School of Medicine and COMM, the ITCG eventually spun off the Division of Imaging & Technology, of which he was founding co-Head. All the while, Prof. Bidaut also kept developing and leading the Clinical Research Imaging Facility (CRIF), a multidisciplinary mixed-role advanced imaging core entity with co-located high-end MRI and PET/CT scanners.

Previously, Luc Bidaut was the founding Director of the Image Processing and Visualization Laboratory (IPVL), Head of the Scientific Computing Resource (SCR) and an Associate Professor in the Department of Imaging Physics at the University of Texas’ M. D. Anderson Cancer Center (MDACC) in Houston, TX-USA. Before then, Luc Bidaut was the founding Technical Director for Advanced Imaging and an Associate Attending/Professor in the Departments of Radiology and Medical Physics at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York, NY-USA. Prior to that, he was project leader and founding Director of the Laboratory of Functional and Multidimensional Imaging (LFMI) across the Departments of Radiology and Surgery at the University Hospitals in Geneva-Switzerland. Earlier still, he was Head of Instrumentation, Imaging and Data Processing and a co-founder of the PET and Biomedical Cyclotron center at the Erasme University Hospital in Brussels-Belgium, where he had moved after working several years as R&D and Computer Scientist in the Division of Biophysics and Nuclear Medicine at the University of California in Los Angeles (UCLA), CA-USA and having previously contributed to PET and SPECT R&D at the Service Hospitalier Frédéric Joliot (SHFJ) in Orsay-France.

2013-2018©European Society for Translational Medicine (EUSTM)